mvr-t7011
immvira pharma
['mvr-t7011']
aacr 2023 | immvira presented preclinical study results of first car-t enabler oncolytic product mvr-t7011 at aacr annual meeting 
We provide a complete array of research services as required for Investigational New Drug Applications (IND).